We continued to assess the effect of DAC treatment on the expression of MAGEA1, MAGEA3/MAGEA6, and MAGEA9 in a broad panel consisting of 37 cell lines originating from female reproductive organ tumors, melanoma, hematopoietic, or other cancers (Figure 1F; Table 1). Here, MAGEA9 is linked to female reproductive system neoplasm.